Stockreport

LB Pharmaceuticals Announces $100.0 Million Private Placement

LB Pharmaceuticals Inc  (LBRX) 
PDF NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company devel [Read more]